Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

NCT07370506 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Doxorubicin Induced Cardiomyopathy

Interventions

DRUG: Telmisartan
DRUG: Doxorubicin (DOX)

Sponsor

Tanta University